

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tryptophan catabolic process (GO:0006569) | 5.42369880 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 5.42369880 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 5.42369880 |
| 4 | aromatic amino acid family catabolic process (GO:0009074) | 5.16753814 |
| 5 | tryptophan metabolic process (GO:0006568) | 5.13245167 |
| 6 | homocysteine metabolic process (GO:0050667) | 4.95241704 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.87300866 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.87300866 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.64797715 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 4.53150652 |
| 11 | regulation of apoptotic cell clearance (GO:2000425) | 4.52588866 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.51144657 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 4.51144657 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.45984775 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 4.42931215 |
| 16 | urea metabolic process (GO:0019627) | 4.29129124 |
| 17 | urea cycle (GO:0000050) | 4.29129124 |
| 18 | protein-lipid complex assembly (GO:0065005) | 4.27961671 |
| 19 | cellular biogenic amine catabolic process (GO:0042402) | 4.27505592 |
| 20 | amine catabolic process (GO:0009310) | 4.27505592 |
| 21 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.26646032 |
| 22 | regulation of plasminogen activation (GO:0010755) | 4.09010969 |
| 23 | indolalkylamine metabolic process (GO:0006586) | 4.01349720 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.01054225 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 3.98236605 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.97103245 |
| 27 | NAD biosynthetic process (GO:0009435) | 3.93955252 |
| 28 | acylglycerol homeostasis (GO:0055090) | 3.92789382 |
| 29 | triglyceride homeostasis (GO:0070328) | 3.92789382 |
| 30 | ethanol oxidation (GO:0006069) | 3.92663144 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.90410150 |
| 32 | phospholipid efflux (GO:0033700) | 3.89554327 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 3.86957475 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 3.86957475 |
| 35 | macromolecular complex remodeling (GO:0034367) | 3.86957475 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 3.84536660 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.83191180 |
| 38 | superoxide anion generation (GO:0042554) | 3.80224228 |
| 39 | negative regulation of lipase activity (GO:0060192) | 3.79908837 |
| 40 | protein-lipid complex subunit organization (GO:0071825) | 3.79097628 |
| 41 | protein carboxylation (GO:0018214) | 3.78722555 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.78722555 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 3.77634251 |
| 44 | biotin metabolic process (GO:0006768) | 3.75812802 |
| 45 | bile acid metabolic process (GO:0008206) | 3.71414701 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 3.71328410 |
| 47 | fibrinolysis (GO:0042730) | 3.62929960 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.62496648 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.60501461 |
| 50 | tyrosine metabolic process (GO:0006570) | 3.58133415 |
| 51 | cellular glucuronidation (GO:0052695) | 3.53543577 |
| 52 | alpha-linolenic acid metabolic process (GO:0036109) | 3.51958531 |
| 53 | linoleic acid metabolic process (GO:0043651) | 3.51207927 |
| 54 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.50166652 |
| 55 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.50166652 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.49921198 |
| 57 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49902382 |
| 58 | low-density lipoprotein particle clearance (GO:0034383) | 3.44936601 |
| 59 | bile acid and bile salt transport (GO:0015721) | 3.43901353 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 3.40179098 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.39250718 |
| 62 | regulation of fibrinolysis (GO:0051917) | 3.38862369 |
| 63 | sulfur amino acid catabolic process (GO:0000098) | 3.37807914 |
| 64 | regulation of complement activation (GO:0030449) | 3.35917664 |
| 65 | glyoxylate metabolic process (GO:0046487) | 3.34211655 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 3.34107623 |
| 67 | negative regulation of complement activation (GO:0045916) | 3.34036813 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 3.33973527 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.32105707 |
| 70 | cholesterol efflux (GO:0033344) | 3.30246455 |
| 71 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.29086084 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.25534900 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.24108416 |
| 74 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.22380681 |
| 75 | ethanol metabolic process (GO:0006067) | 3.21929147 |
| 76 | valine metabolic process (GO:0006573) | 3.21591822 |
| 77 | negative regulation of fibrinolysis (GO:0051918) | 3.18462921 |
| 78 | neutral lipid catabolic process (GO:0046461) | 3.16925262 |
| 79 | acylglycerol catabolic process (GO:0046464) | 3.16925262 |
| 80 | negative regulation of blood coagulation (GO:0030195) | 3.16861790 |
| 81 | negative regulation of hemostasis (GO:1900047) | 3.16861790 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13874944 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.12511472 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.12511472 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.12350938 |
| 86 | opsonization (GO:0008228) | 3.10434487 |
| 87 | carnitine metabolic process (GO:0009437) | 3.09578421 |
| 88 | glutamate metabolic process (GO:0006536) | 3.09188606 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 3.09149387 |
| 90 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.05642444 |
| 91 | cysteine metabolic process (GO:0006534) | 3.03737847 |
| 92 | branched-chain amino acid catabolic process (GO:0009083) | 3.03114907 |
| 93 | plasma lipoprotein particle organization (GO:0071827) | 3.02973605 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.02704278 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.02621571 |
| 96 | positive regulation of hemostasis (GO:1900048) | 3.00395699 |
| 97 | positive regulation of blood coagulation (GO:0030194) | 3.00395699 |
| 98 | regulation of humoral immune response (GO:0002920) | 3.00296649 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 2.97613609 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 2.96417969 |
| 101 | drug catabolic process (GO:0042737) | 2.96021857 |
| 102 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95883518 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 2.95749481 |
| 104 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.95353087 |
| 105 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.95257428 |
| 106 | response to mercury ion (GO:0046689) | 2.94179075 |
| 107 | complement activation, classical pathway (GO:0006958) | 2.93532531 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92340835 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92340835 |
| 110 | cholesterol homeostasis (GO:0042632) | 2.92201915 |
| 111 | negative regulation of coagulation (GO:0050819) | 2.91954809 |
| 112 | fatty acid oxidation (GO:0019395) | 2.90818809 |
| 113 | triglyceride catabolic process (GO:0019433) | 2.90147304 |
| 114 | intestinal absorption (GO:0050892) | 2.88448705 |
| 115 | sterol homeostasis (GO:0055092) | 2.88377305 |
| 116 | arginine metabolic process (GO:0006525) | 2.88058654 |
| 117 | lipid oxidation (GO:0034440) | 2.87514959 |
| 118 | lipoprotein metabolic process (GO:0042157) | 2.86787708 |
| 119 | acute-phase response (GO:0006953) | 2.86726274 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 2.86711952 |
| 121 | organic acid catabolic process (GO:0016054) | 2.86711952 |
| 122 | diacylglycerol metabolic process (GO:0046339) | 2.86376886 |
| 123 | protein activation cascade (GO:0072376) | 2.86214092 |
| 124 | negative regulation of wound healing (GO:0061045) | 2.85057190 |
| 125 | sterol transport (GO:0015918) | 2.84369048 |
| 126 | cholesterol transport (GO:0030301) | 2.84369048 |
| 127 | negative regulation of protein activation cascade (GO:2000258) | 2.84326058 |
| 128 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83484659 |
| 129 | monocarboxylic acid catabolic process (GO:0072329) | 2.83044448 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 2.83012859 |
| 131 | androgen biosynthetic process (GO:0006702) | 2.81761833 |
| 132 | negative regulation of cholesterol transport (GO:0032375) | 2.81134440 |
| 133 | negative regulation of sterol transport (GO:0032372) | 2.81134440 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.80713145 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 2.79286005 |
| 136 | fatty acid catabolic process (GO:0009062) | 2.78364315 |
| 137 | branched-chain amino acid metabolic process (GO:0009081) | 2.77615068 |
| 138 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.76160334 |
| 139 | positive regulation of coagulation (GO:0050820) | 2.75751553 |
| 140 | regulation of cholesterol homeostasis (GO:2000188) | 2.72572891 |
| 141 | glycine metabolic process (GO:0006544) | 2.71390619 |
| 142 | negative regulation of sodium ion transport (GO:0010766) | 2.67939524 |
| 143 | complement activation (GO:0006956) | 2.63535286 |
| 144 | omega-hydroxylase P450 pathway (GO:0097267) | 2.62394904 |
| 145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.61907143 |
| 146 | regulation of cholesterol metabolic process (GO:0090181) | 2.61170375 |
| 147 | fatty acid homeostasis (GO:0055089) | 2.60865684 |
| 148 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.59449767 |
| 149 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.59379535 |
| 150 | lipid homeostasis (GO:0055088) | 2.58433699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.47131423 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.44768901 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48274587 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.35973806 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.29333988 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.00262257 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87172370 |
| 8 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.71093051 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.65502459 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.55489454 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45240501 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.45167482 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.41358265 |
| 14 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.34837197 |
| 15 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.26310317 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.25812685 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.24934665 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.22050648 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.16418445 |
| 20 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.13159929 |
| 21 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10561470 |
| 22 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.01461427 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98337505 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94530092 |
| 25 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.87222887 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80299668 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.76277389 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73025925 |
| 29 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.72783814 |
| 30 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.72638797 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.69637044 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.69119110 |
| 33 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.68185185 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67078342 |
| 35 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.64483775 |
| 36 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.64062373 |
| 37 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.62409489 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.62404318 |
| 39 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.60852570 |
| 40 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.60511318 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.60339101 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60197973 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59205075 |
| 44 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.58437940 |
| 45 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.58335226 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57886757 |
| 47 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.56981440 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55313661 |
| 49 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.54738523 |
| 50 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.51402251 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51309249 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51201259 |
| 53 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.50647262 |
| 54 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.50611046 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50108468 |
| 56 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.48670415 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.48661196 |
| 58 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.48599462 |
| 59 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.48561056 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47714141 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46211290 |
| 62 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.45988380 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45780864 |
| 64 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.43151017 |
| 65 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.43147478 |
| 66 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.42658849 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41012250 |
| 68 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.39542676 |
| 69 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.39261958 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38640802 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35992703 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34580700 |
| 73 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34418944 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34395109 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34230006 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34126990 |
| 77 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.34106566 |
| 78 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.33322184 |
| 79 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.32618953 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31975494 |
| 81 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.30056254 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29980841 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29689521 |
| 84 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28681429 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28524050 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28468346 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28344396 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26358536 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25501222 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25280078 |
| 91 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24864903 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24465020 |
| 93 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24413835 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24379285 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22112001 |
| 96 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.21915011 |
| 97 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.21337557 |
| 98 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.20457613 |
| 99 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20435420 |
| 100 | KDM2B_26808549_Chip-Seq_REH_Human | 1.19915581 |
| 101 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.19903811 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19576046 |
| 103 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19093942 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19029282 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18070981 |
| 106 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.17430383 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16106445 |
| 108 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.14251141 |
| 109 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.11741417 |
| 110 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.11289111 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10709421 |
| 112 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08361475 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07960142 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06265347 |
| 115 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04991854 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04850598 |
| 117 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04622668 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04379634 |
| 119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03400852 |
| 120 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03269546 |
| 121 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03146283 |
| 122 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.02067537 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99690917 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99690917 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98340374 |
| 126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98111389 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98026908 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98026908 |
| 129 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97565109 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96562321 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95618129 |
| 132 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95233574 |
| 133 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95233574 |
| 134 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95233574 |
| 135 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.95182761 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95138895 |
| 137 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94677464 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94669052 |
| 139 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.93648016 |
| 140 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.93648016 |
| 141 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93619411 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93276451 |
| 143 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93067079 |
| 144 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92925556 |
| 145 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.92410596 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92120515 |
| 147 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92076584 |
| 148 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.91646681 |
| 149 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91406384 |
| 150 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.91353191 |
| 151 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91103648 |
| 152 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91071489 |
| 153 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90022321 |
| 154 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89729568 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89556078 |
| 156 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88922399 |
| 157 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.88499473 |
| 158 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.87660966 |
| 159 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87451889 |
| 160 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87198674 |
| 161 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86784838 |
| 162 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86244099 |
| 163 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85466049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.52701392 |
| 2 | MP0005360_urolithiasis | 5.75192727 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.16037321 |
| 4 | MP0005365_abnormal_bile_salt | 5.15957686 |
| 5 | MP0003122_maternal_imprinting | 3.77673140 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.49713371 |
| 7 | MP0003252_abnormal_bile_duct | 3.28544489 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.23728321 |
| 9 | MP0009697_abnormal_copulation | 3.12854976 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.08306639 |
| 11 | MP0005670_abnormal_white_adipose | 2.93344213 |
| 12 | MP0003195_calcinosis | 2.80494506 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.74941089 |
| 14 | MP0000566_synostosis | 2.47870813 |
| 15 | MP0004272_abnormal_basement_membrane | 2.30381565 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.30364461 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.27644461 |
| 18 | MP0005451_abnormal_body_composition | 2.16436416 |
| 19 | MP0003011_delayed_dark_adaptation | 2.15017120 |
| 20 | MP0003890_abnormal_embryonic-extraembry | 2.11458675 |
| 21 | MP0003123_paternal_imprinting | 2.03433885 |
| 22 | MP0009764_decreased_sensitivity_to | 1.98249015 |
| 23 | MP0005332_abnormal_amino_acid | 1.93850242 |
| 24 | MP0001764_abnormal_homeostasis | 1.90519265 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.89322374 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.89275818 |
| 27 | MP0005647_abnormal_sex_gland | 1.81358239 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.75376885 |
| 29 | MP0005083_abnormal_biliary_tract | 1.68606342 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.68413587 |
| 31 | MP0003868_abnormal_feces_composition | 1.65431667 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.61436627 |
| 33 | MP0003878_abnormal_ear_physiology | 1.60972816 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.60972816 |
| 35 | MP0005408_hypopigmentation | 1.59079724 |
| 36 | MP0003724_increased_susceptibility_to | 1.57223659 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.56089329 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.55831499 |
| 39 | MP0001188_hyperpigmentation | 1.52481805 |
| 40 | MP0000609_abnormal_liver_physiology | 1.48617639 |
| 41 | MP0003186_abnormal_redox_activity | 1.45061000 |
| 42 | MP0003121_genomic_imprinting | 1.44117025 |
| 43 | MP0002132_abnormal_respiratory_system | 1.44082921 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.43315697 |
| 45 | MP0002089_abnormal_postnatal_growth/wei | 1.42348062 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.42003528 |
| 47 | MP0009384_cardiac_valve_regurgitation | 1.40262575 |
| 48 | MP0002938_white_spotting | 1.40031341 |
| 49 | MP0006054_spinal_hemorrhage | 1.35202350 |
| 50 | MP0001915_intracranial_hemorrhage | 1.34113058 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.29765700 |
| 52 | MP0003942_abnormal_urinary_system | 1.27264962 |
| 53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.26029656 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.22779003 |
| 55 | MP0002697_abnormal_eye_size | 1.19362660 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.15397634 |
| 57 | MP0002254_reproductive_system_inflammat | 1.14848082 |
| 58 | MP0001293_anophthalmia | 1.14809659 |
| 59 | MP0003937_abnormal_limbs/digits/tail_de | 1.14438425 |
| 60 | MP0005334_abnormal_fat_pad | 1.13636945 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.12590615 |
| 62 | MP0002971_abnormal_brown_adipose | 1.09349155 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09253766 |
| 64 | MP0002233_abnormal_nose_morphology | 1.08144203 |
| 65 | MP0001984_abnormal_olfaction | 1.05552919 |
| 66 | MP0005248_abnormal_Harderian_gland | 1.03842343 |
| 67 | MP0005535_abnormal_body_temperature | 1.03780011 |
| 68 | MP0009840_abnormal_foam_cell | 1.03635329 |
| 69 | MP0004130_abnormal_muscle_cell | 1.02955732 |
| 70 | MP0005171_absent_coat_pigmentation | 1.02097979 |
| 71 | MP0009672_abnormal_birth_weight | 0.98608951 |
| 72 | MP0009785_altered_susceptibility_to | 0.97866636 |
| 73 | MP0002102_abnormal_ear_morphology | 0.96278524 |
| 74 | MP0001299_abnormal_eye_distance/ | 0.95921375 |
| 75 | MP0009763_increased_sensitivity_to | 0.95880908 |
| 76 | MP0004381_abnormal_hair_follicle | 0.95426789 |
| 77 | MP0001835_abnormal_antigen_presentation | 0.93605312 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.93097123 |
| 79 | MP0003119_abnormal_digestive_system | 0.92047070 |
| 80 | MP0003941_abnormal_skin_development | 0.91756652 |
| 81 | MP0003115_abnormal_respiratory_system | 0.91467716 |
| 82 | MP0008469_abnormal_protein_level | 0.89912368 |
| 83 | MP0000751_myopathy | 0.89675389 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.88966861 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.88907516 |
| 86 | MP0008260_abnormal_autophagy | 0.88689824 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.87521005 |
| 88 | MP0004133_heterotaxia | 0.87035832 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.86700075 |
| 90 | MP0009115_abnormal_fat_cell | 0.86579767 |
| 91 | MP0002928_abnormal_bile_duct | 0.86235344 |
| 92 | MP0006138_congestive_heart_failure | 0.85625929 |
| 93 | MP0008004_abnormal_stomach_pH | 0.85412394 |
| 94 | MP0001346_abnormal_lacrimal_gland | 0.84924272 |
| 95 | MP0000579_abnormal_nail_morphology | 0.83596381 |
| 96 | MP0003632_abnormal_nervous_system | 0.82850832 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.81980023 |
| 98 | MP0003385_abnormal_body_wall | 0.81872896 |
| 99 | MP0003690_abnormal_glial_cell | 0.80477284 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.79413560 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.78840677 |
| 102 | MP0001286_abnormal_eye_development | 0.78832170 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.78378352 |
| 104 | MP0010630_abnormal_cardiac_muscle | 0.76747026 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.76013970 |
| 106 | MP0002092_abnormal_eye_morphology | 0.75872332 |
| 107 | MP0002419_abnormal_innate_immunity | 0.75421411 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.73675805 |
| 109 | MP0005503_abnormal_tendon_morphology | 0.70696168 |
| 110 | MP0000681_abnormal_thyroid_gland | 0.70532232 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.69832549 |
| 112 | MP0000427_abnormal_hair_cycle | 0.69098489 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.68420901 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.68372734 |
| 115 | MP0005187_abnormal_penis_morphology | 0.68038810 |
| 116 | MP0001502_abnormal_circadian_rhythm | 0.67957798 |
| 117 | MP0002128_abnormal_blood_circulation | 0.66998726 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.65915673 |
| 119 | MP0002282_abnormal_trachea_morphology | 0.65791834 |
| 120 | MP0005330_cardiomyopathy | 0.65210675 |
| 121 | MP0003136_yellow_coat_color | 0.64990775 |
| 122 | MP0005448_abnormal_energy_balance | 0.64976493 |
| 123 | MP0003329_amyloid_beta_deposits | 0.64682105 |
| 124 | MP0002168_other_aberrant_phenotype | 0.64425379 |
| 125 | MP0004084_abnormal_cardiac_muscle | 0.64076887 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.63909064 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.63609539 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.63017308 |
| 129 | MP0001324_abnormal_eye_pigmentation | 0.62804220 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.62268974 |
| 131 | MP0001661_extended_life_span | 0.62252299 |
| 132 | MP0001177_atelectasis | 0.61920951 |
| 133 | MP0005551_abnormal_eye_electrophysiolog | 0.61869656 |
| 134 | MP0001119_abnormal_female_reproductive | 0.61790171 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.61782633 |
| 136 | MP0002060_abnormal_skin_morphology | 0.61078583 |
| 137 | MP0009053_abnormal_anal_canal | 0.59245151 |
| 138 | MP0002295_abnormal_pulmonary_circulatio | 0.59080104 |
| 139 | MP0000569_abnormal_digit_pigmentation | 0.58931772 |
| 140 | MP0000598_abnormal_liver_morphology | 0.58338858 |
| 141 | MP0010386_abnormal_urinary_bladder | 0.58154246 |
| 142 | MP0005395_other_phenotype | 0.58028667 |
| 143 | MP0008775_abnormal_heart_ventricle | 0.57116363 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.56909616 |
| 145 | MP0000428_abnormal_craniofacial_morphol | 0.56806186 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.56362283 |
| 147 | MP0004087_abnormal_muscle_fiber | 0.56329508 |
| 148 | MP0002896_abnormal_bone_mineralization | 0.55465919 |
| 149 | MP0002269_muscular_atrophy | 0.55283320 |
| 150 | MP0001529_abnormal_vocalization | 0.55051986 |
| 151 | MP0005025_abnormal_response_to | 0.54790653 |
| 152 | MP0002249_abnormal_larynx_morphology | 0.53850437 |
| 153 | MP0000538_abnormal_urinary_bladder | 0.53834569 |
| 154 | MP0003436_decreased_susceptibility_to | 0.53781222 |
| 155 | MP0009703_decreased_birth_body | 0.53689308 |
| 156 | MP0002136_abnormal_kidney_physiology | 0.53676367 |
| 157 | MP0004147_increased_porphyrin_level | 0.53607162 |
| 158 | MP0000762_abnormal_tongue_morphology | 0.53291491 |
| 159 | MP0004185_abnormal_adipocyte_glucose | 0.53146157 |
| 160 | MP0003953_abnormal_hormone_level | 0.53057775 |
| 161 | MP0006082_CNS_inflammation | 0.52557388 |
| 162 | MP0006276_abnormal_autonomic_nervous | 0.51587267 |
| 163 | MP0005220_abnormal_exocrine_pancreas | 0.50757589 |
| 164 | MP0005376_homeostasis/metabolism_phenot | 0.47161636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 5.48984627 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.07002452 |
| 3 | Joint hemorrhage (HP:0005261) | 4.94535328 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.28854517 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.20258308 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.95721022 |
| 7 | Epidermoid cyst (HP:0200040) | 3.94345870 |
| 8 | Renal cortical cysts (HP:0000803) | 3.85465499 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 3.85321443 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.79519158 |
| 11 | Xanthomatosis (HP:0000991) | 3.62220227 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.60000500 |
| 13 | Hyperglycinuria (HP:0003108) | 3.55685583 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.50241622 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.46612673 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 3.38787677 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.36679634 |
| 18 | Complement deficiency (HP:0004431) | 3.33932385 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.28422426 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.25032076 |
| 21 | Hyperammonemia (HP:0001987) | 3.23730544 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.17542109 |
| 23 | Hyperglycinemia (HP:0002154) | 3.14295790 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.07949020 |
| 25 | Chromsome breakage (HP:0040012) | 3.06614751 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.06561258 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.06561258 |
| 28 | Vascular calcification (HP:0004934) | 3.02321561 |
| 29 | Fat malabsorption (HP:0002630) | 2.99009838 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98374960 |
| 31 | Chronic hepatic failure (HP:0100626) | 2.92600182 |
| 32 | Prostate neoplasm (HP:0100787) | 2.91727591 |
| 33 | Hepatoblastoma (HP:0002884) | 2.88003456 |
| 34 | Small epiphyses (HP:0010585) | 2.87831279 |
| 35 | Abnormality of carpal bone ossification (HP:0006257) | 2.80375151 |
| 36 | Abnormal tarsal ossification (HP:0008369) | 2.79991029 |
| 37 | Fair hair (HP:0002286) | 2.77576427 |
| 38 | Cardiovascular calcification (HP:0011915) | 2.74353650 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73398393 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73385036 |
| 41 | Hyperventilation (HP:0002883) | 2.73157069 |
| 42 | Nephritis (HP:0000123) | 2.69152287 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.68876393 |
| 44 | Gingival bleeding (HP:0000225) | 2.66724709 |
| 45 | Hypophosphatemic rickets (HP:0004912) | 2.64874551 |
| 46 | Acanthocytosis (HP:0001927) | 2.64552668 |
| 47 | Alveolar cell carcinoma (HP:0006519) | 2.64301684 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.60526017 |
| 49 | Enlarged kidneys (HP:0000105) | 2.57596379 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.57006427 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56713321 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.55095920 |
| 53 | Bile duct proliferation (HP:0001408) | 2.50716895 |
| 54 | Abnormal biliary tract physiology (HP:0012439) | 2.50716895 |
| 55 | Hemorrhage of the eye (HP:0011885) | 2.49546728 |
| 56 | Ketosis (HP:0001946) | 2.48700873 |
| 57 | Myocardial infarction (HP:0001658) | 2.48597527 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.45871611 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45296401 |
| 60 | Osteomalacia (HP:0002749) | 2.45150381 |
| 61 | Menorrhagia (HP:0000132) | 2.43082338 |
| 62 | Abnormality of the renal cortex (HP:0011035) | 2.38925869 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.37296725 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.35531983 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35013735 |
| 66 | Steatorrhea (HP:0002570) | 2.33932590 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33374092 |
| 68 | Arthropathy (HP:0003040) | 2.33284717 |
| 69 | Increased serum pyruvate (HP:0003542) | 2.30680997 |
| 70 | Choanal stenosis (HP:0000452) | 2.30369645 |
| 71 | Pancreatitis (HP:0001733) | 2.29897605 |
| 72 | Neonatal hypoglycemia (HP:0001998) | 2.29104632 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.28654072 |
| 74 | Abnormality of complement system (HP:0005339) | 2.25978518 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.25672548 |
| 76 | Thyroid-stimulating hormone excess (HP:0002925) | 2.25264458 |
| 77 | Febrile seizures (HP:0002373) | 2.25059860 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.24444390 |
| 79 | Vaginal fistula (HP:0004320) | 2.23598185 |
| 80 | Abnormality of glycolysis (HP:0004366) | 2.23082831 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.20841082 |
| 82 | Abnormal hand bone ossification (HP:0010660) | 2.20439796 |
| 83 | Broad alveolar ridges (HP:0000187) | 2.20370832 |
| 84 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.20037863 |
| 85 | Metabolic acidosis (HP:0001942) | 2.16837321 |
| 86 | Skin nodule (HP:0200036) | 2.16779848 |
| 87 | Tubulointerstitial nephritis (HP:0001970) | 2.16334500 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.15947577 |
| 89 | Hydroxyprolinuria (HP:0003080) | 2.15947577 |
| 90 | Azoospermia (HP:0000027) | 2.12256943 |
| 91 | Abnormal ossification of hand bones (HP:0005921) | 2.08457844 |
| 92 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07643175 |
| 93 | Alacrima (HP:0000522) | 2.05608612 |
| 94 | Potter facies (HP:0002009) | 2.05321356 |
| 95 | Facial shape deformation (HP:0011334) | 2.05321356 |
| 96 | Neonatal short-limb short stature (HP:0008921) | 2.04612462 |
| 97 | Bronchomalacia (HP:0002780) | 2.04351786 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 2.04033232 |
| 99 | Spontaneous abortion (HP:0005268) | 2.01508654 |
| 100 | Mesomelia (HP:0003027) | 2.01001026 |
| 101 | Broad palm (HP:0001169) | 2.00830777 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.00715359 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00715359 |
| 104 | Myelomeningocele (HP:0002475) | 2.00125043 |
| 105 | Abnormality of the pubic bones (HP:0003172) | 1.99672737 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 1.99236592 |
| 107 | Pigmentary retinal degeneration (HP:0001146) | 1.98387257 |
| 108 | Proximal tubulopathy (HP:0000114) | 1.98256996 |
| 109 | Papillary thyroid carcinoma (HP:0002895) | 1.98103660 |
| 110 | Lethargy (HP:0001254) | 1.97973515 |
| 111 | Asymmetry of the thorax (HP:0001555) | 1.97282911 |
| 112 | Symptomatic seizures (HP:0011145) | 1.96630235 |
| 113 | Epiphyseal dysplasia (HP:0002656) | 1.94811563 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 1.94638265 |
| 115 | Supernumerary spleens (HP:0009799) | 1.94406087 |
| 116 | Bifid scrotum (HP:0000048) | 1.94023365 |
| 117 | Hypothermia (HP:0002045) | 1.92603990 |
| 118 | Elevated hepatic transaminases (HP:0002910) | 1.92603202 |
| 119 | Oligomenorrhea (HP:0000876) | 1.92393668 |
| 120 | Generalized aminoaciduria (HP:0002909) | 1.91795117 |
| 121 | Opisthotonus (HP:0002179) | 1.91720406 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.90441899 |
| 123 | Back pain (HP:0003418) | 1.88157122 |
| 124 | Delayed CNS myelination (HP:0002188) | 1.88108733 |
| 125 | Prolonged neonatal jaundice (HP:0006579) | 1.88034745 |
| 126 | Flat acetabular roof (HP:0003180) | 1.87138461 |
| 127 | Glomerulonephritis (HP:0000099) | 1.86881873 |
| 128 | Irregular epiphyses (HP:0010582) | 1.86426537 |
| 129 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85769326 |
| 130 | Midline defect of the nose (HP:0004122) | 1.85505462 |
| 131 | Abnormal delivery (HP:0001787) | 1.83812247 |
| 132 | Joint swelling (HP:0001386) | 1.82537344 |
| 133 | Mitral stenosis (HP:0001718) | 1.81484199 |
| 134 | Cerebral edema (HP:0002181) | 1.78011514 |
| 135 | Blue irides (HP:0000635) | 1.75466042 |
| 136 | Anophthalmia (HP:0000528) | 1.74974603 |
| 137 | Arterial tortuosity (HP:0005116) | 1.74308836 |
| 138 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.74304514 |
| 139 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74304514 |
| 140 | Aplasia involving bones of the extremities (HP:0009825) | 1.74304514 |
| 141 | Prominent supraorbital ridges (HP:0000336) | 1.73234822 |
| 142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.73190429 |
| 143 | Rickets (HP:0002748) | 1.73113137 |
| 144 | Coronal craniosynostosis (HP:0004440) | 1.71777377 |
| 145 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.70167346 |
| 146 | Decreased lacrimation (HP:0000633) | 1.70113338 |
| 147 | Absent eyebrow (HP:0002223) | 1.65454278 |
| 148 | Limited elbow extension (HP:0001377) | 1.65319314 |
| 149 | Abnormality of the nasal septum (HP:0000419) | 1.64619631 |
| 150 | Vascular tortuosity (HP:0004948) | 1.63520032 |
| 151 | Abnormality of the lacrimal duct (HP:0011481) | 1.63490512 |
| 152 | Partial duplication of thumb phalanx (HP:0009944) | 1.62969477 |
| 153 | Absent epiphyses (HP:0010577) | 1.62400004 |
| 154 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.62400004 |
| 155 | Bifid tongue (HP:0010297) | 1.59096664 |
| 156 | Abnormal foot bone ossification (HP:0010675) | 1.58429272 |
| 157 | Diastasis recti (HP:0001540) | 1.57687696 |
| 158 | Abnormality of pain sensation (HP:0010832) | 1.57170957 |
| 159 | Impaired pain sensation (HP:0007328) | 1.57170957 |
| 160 | Prenatal maternal abnormality (HP:0002686) | 1.56735306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.82652852 |
| 2 | INSRR | 3.32744046 |
| 3 | IRAK3 | 2.86664219 |
| 4 | MAP3K14 | 2.73624999 |
| 5 | EIF2AK2 | 2.59141338 |
| 6 | PDGFRA | 2.45962115 |
| 7 | PKN2 | 2.31281227 |
| 8 | ZAK | 2.30220996 |
| 9 | FGFR1 | 2.21641940 |
| 10 | PRPF4B | 2.20600135 |
| 11 | TYRO3 | 2.17645350 |
| 12 | TXK | 2.15146172 |
| 13 | RIPK1 | 2.07986284 |
| 14 | STK38L | 2.07446920 |
| 15 | TNIK | 2.06211467 |
| 16 | PIK3CG | 2.04192769 |
| 17 | SIK1 | 2.02646891 |
| 18 | BCKDK | 2.02308169 |
| 19 | LATS2 | 1.92769000 |
| 20 | MAP2K7 | 1.90676363 |
| 21 | WNK4 | 1.87075347 |
| 22 | FRK | 1.84798787 |
| 23 | GRK1 | 1.83604960 |
| 24 | CAMK1D | 1.79531512 |
| 25 | NUAK1 | 1.68223544 |
| 26 | TAOK2 | 1.65045823 |
| 27 | TIE1 | 1.64745868 |
| 28 | WNK3 | 1.60488160 |
| 29 | TAOK3 | 1.59482056 |
| 30 | AKT3 | 1.58241237 |
| 31 | YES1 | 1.54882470 |
| 32 | ADRBK2 | 1.50101484 |
| 33 | SGK2 | 1.49071864 |
| 34 | PINK1 | 1.46404108 |
| 35 | DDR2 | 1.43646983 |
| 36 | IRAK4 | 1.42906548 |
| 37 | ICK | 1.40746888 |
| 38 | JAK1 | 1.39449746 |
| 39 | LATS1 | 1.37679807 |
| 40 | TEC | 1.36675402 |
| 41 | TRIB3 | 1.32812963 |
| 42 | MST1R | 1.29789927 |
| 43 | CDK12 | 1.26471166 |
| 44 | ERBB4 | 1.25251371 |
| 45 | EEF2K | 1.23053523 |
| 46 | RET | 1.22286470 |
| 47 | NLK | 1.20736558 |
| 48 | BMPR2 | 1.17234288 |
| 49 | FGFR4 | 1.15772782 |
| 50 | NTRK2 | 1.09113183 |
| 51 | SIK3 | 1.08043936 |
| 52 | EPHA3 | 1.07102595 |
| 53 | IKBKE | 1.06108580 |
| 54 | TGFBR2 | 1.04564155 |
| 55 | NEK6 | 1.03567807 |
| 56 | PRKAA2 | 1.03310116 |
| 57 | IKBKB | 1.02223313 |
| 58 | ERBB2 | 1.01747252 |
| 59 | NTRK1 | 1.01236986 |
| 60 | IRAK1 | 1.00713253 |
| 61 | WNK1 | 0.99903627 |
| 62 | PIK3CA | 0.98762992 |
| 63 | CDK3 | 0.96463094 |
| 64 | JAK3 | 0.96003304 |
| 65 | NEK2 | 0.92887372 |
| 66 | STK16 | 0.92291348 |
| 67 | TNK2 | 0.91061090 |
| 68 | NEK9 | 0.90659302 |
| 69 | BRSK2 | 0.88963004 |
| 70 | DMPK | 0.87150335 |
| 71 | SGK3 | 0.87044955 |
| 72 | GRK7 | 0.85485709 |
| 73 | TRPM7 | 0.84009798 |
| 74 | DYRK1B | 0.83107598 |
| 75 | MAPK7 | 0.81496646 |
| 76 | CAMK1G | 0.80245691 |
| 77 | MARK1 | 0.80096855 |
| 78 | PLK3 | 0.79057864 |
| 79 | MAPKAPK3 | 0.78701728 |
| 80 | NEK1 | 0.78454502 |
| 81 | STK39 | 0.77927270 |
| 82 | CSNK1E | 0.76729494 |
| 83 | SGK223 | 0.76635811 |
| 84 | SGK494 | 0.76635811 |
| 85 | TBK1 | 0.76494021 |
| 86 | FGFR3 | 0.73846800 |
| 87 | MAP3K3 | 0.73628141 |
| 88 | CHUK | 0.73104335 |
| 89 | PNCK | 0.72551856 |
| 90 | PKN1 | 0.72364403 |
| 91 | MKNK1 | 0.69458245 |
| 92 | PAK2 | 0.68773533 |
| 93 | DAPK2 | 0.67754186 |
| 94 | PRKCE | 0.67328330 |
| 95 | PLK2 | 0.66160020 |
| 96 | PDGFRB | 0.66029166 |
| 97 | PRKCG | 0.65197632 |
| 98 | TYK2 | 0.63798020 |
| 99 | FLT3 | 0.63177023 |
| 100 | MUSK | 0.62402144 |
| 101 | IRAK2 | 0.61687632 |
| 102 | PBK | 0.60537886 |
| 103 | LMTK2 | 0.60228032 |
| 104 | MAPK11 | 0.60050286 |
| 105 | PDK2 | 0.59605227 |
| 106 | STK3 | 0.58432908 |
| 107 | ERBB3 | 0.57041781 |
| 108 | MTOR | 0.57005250 |
| 109 | FGFR2 | 0.56113362 |
| 110 | PLK4 | 0.55103111 |
| 111 | TTK | 0.54214691 |
| 112 | OBSCN | 0.54089245 |
| 113 | MET | 0.53455863 |
| 114 | PDPK1 | 0.52918767 |
| 115 | PRKACB | 0.52749452 |
| 116 | DYRK2 | 0.51360856 |
| 117 | MKNK2 | 0.50807254 |
| 118 | RPS6KB1 | 0.50649264 |
| 119 | CSNK1D | 0.49904298 |
| 120 | NTRK3 | 0.49509424 |
| 121 | BRD4 | 0.49202237 |
| 122 | MAPK13 | 0.49114955 |
| 123 | FER | 0.48594353 |
| 124 | STK24 | 0.48312530 |
| 125 | CAMK2D | 0.47570777 |
| 126 | PRKAA1 | 0.47515069 |
| 127 | MAP3K4 | 0.46295059 |
| 128 | BRSK1 | 0.45571075 |
| 129 | MYLK | 0.45374979 |
| 130 | LYN | 0.45246267 |
| 131 | BCR | 0.44859741 |
| 132 | CDK6 | 0.44729911 |
| 133 | RPS6KA3 | 0.44697135 |
| 134 | IGF1R | 0.44185083 |
| 135 | BMPR1B | 0.43771977 |
| 136 | EPHA4 | 0.42303529 |
| 137 | PRKCQ | 0.40853901 |
| 138 | PRKG1 | 0.40581635 |
| 139 | SGK1 | 0.40142822 |
| 140 | JAK2 | 0.40029421 |
| 141 | MELK | 0.39971792 |
| 142 | PRKCZ | 0.39505223 |
| 143 | MAPK10 | 0.39454036 |
| 144 | CDK7 | 0.39257497 |
| 145 | KIT | 0.38804706 |
| 146 | CAMK2B | 0.38414127 |
| 147 | EIF2AK3 | 0.38303534 |
| 148 | CAMK1 | 0.36733735 |
| 149 | ROCK2 | 0.36665420 |
| 150 | PRKACG | 0.36644676 |
| 151 | EIF2AK1 | 0.36536720 |
| 152 | CDK8 | 0.35917438 |
| 153 | SRPK1 | 0.35587026 |
| 154 | CAMK4 | 0.35442684 |
| 155 | AKT2 | 0.35090185 |
| 156 | PRKDC | 0.34747656 |
| 157 | CSF1R | 0.34561825 |
| 158 | PRKACA | 0.34374895 |
| 159 | MAP2K3 | 0.34306346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.72592693 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95835469 |
| 3 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64293520 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62398673 |
| 5 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.58721310 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51998314 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51459946 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47578508 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44649777 |
| 10 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.44349606 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.34137604 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.28242582 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.26330268 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24665868 |
| 15 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.22690438 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15254729 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15029353 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12274588 |
| 19 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.08061650 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05546761 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99328782 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98972765 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.94842102 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81238839 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80115239 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78970357 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78259995 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.76076160 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.73970357 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70524691 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69660561 |
| 32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62161479 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59156611 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58317750 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50317567 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49126952 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33512185 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25827322 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25395292 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25009977 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24799757 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.23050529 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15883395 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14113259 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07185322 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06114184 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06034853 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 0.98063485 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95976926 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94027628 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90983793 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90866800 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89463822 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88147606 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.87067511 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85995702 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83966302 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80116079 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.74205598 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69123715 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67551160 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63309236 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62710243 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60654907 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60425768 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58701759 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53980119 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53140947 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52653419 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52028928 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51079549 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50741223 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49208985 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48264938 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47850845 |
| 76 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47734833 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.47443961 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47144992 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46104265 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45951532 |
| 81 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45860102 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45856465 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45507487 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45378330 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43064287 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.42463383 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39412841 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39401086 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37487677 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37037425 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36232510 |
| 92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36026206 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35057624 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32937971 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31638556 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30293711 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.29502366 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29176506 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29042481 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28669556 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27210572 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26500788 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24723189 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24722556 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24085507 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23467394 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.23109570 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23062613 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.22898460 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.21873395 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20999282 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20449600 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20230605 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19853618 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.19838297 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19036594 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18951982 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.18865629 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.18152534 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.17137626 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16742540 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.16488574 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.15767816 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15525803 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13912305 |
| 126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.13895151 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.13834670 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13588629 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.13139873 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12661456 |
| 131 | Axon guidance_Homo sapiens_hsa04360 | 0.12298016 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.11583414 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.10996552 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10355995 |

